Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent Paclitaxel and Radiation in LABC
NCT02280252Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Mar 2005
- Primary completion
- Dec 2018
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in breast cancer, sponsored by NYU Langone Health. Started Mar 2005; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02280252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280252.